SCHEDULE: KP Biotech Discloses 0.9% Stake in TuHURA Biosciences

KP Biotech Group LLC has disclosed a 0.9% beneficial ownership stake in TuHURA Biosciences, Inc., holding 447,232 shares of common stock.

Summary

• KP Biotech Group LLC beneficially owns 447,232 shares of TuHURA Biosciences, Inc. Common Stock.
• This ownership represents 0.9% of the total outstanding shares of TuHURA Biosciences, Inc.
• The percentage of ownership is calculated based on 50,046,926 shares outstanding as of August 11, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q.
• KP Biotech Group LLC holds sole voting power and sole dispositive power over all 447,232 shares.
• The shares were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: This Schedule 13G filing is a routine disclosure of beneficial ownership, indicating a neutral stance. The reported ownership of 0.9% is a small, non-controlling stake, which typically has minimal direct impact on company operations or market sentiment.

Risks

• The filing explicitly states that the shares are not held for the purpose of changing or influencing control of the issuer, mitigating potential activist investor risks from this specific holder.

Stakeholder Impact

• Shareholders: Minimal direct impact due to the small, non-controlling nature of the stake.
• Management: No direct impact on management or strategic direction as the stake is not for control purposes.

Key Dates

Keywords

TuHURA Biosciences, KP Biotech Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Biotechnology, Investment Disclosure